Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status

INTRODUCTION: Concurrent ONce-daily VErsus twice-daily RadioTherapy (CONVERT) is the only multicentre, international, randomised, phase III trial open in Europe and Canada looking at optimisation of chemoradiotherapy (RT) in limited stage small cell lung cancer (LS-SCLC). Following on from the Turri...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Open
Hlavní autoři: Faivre-Finn, Corinne, Falk, Sally, Ashcroft, Linda, Bewley, Michelle, Lorigan, Paul, Wilson, Elena, Groom, Nicki, Snee, Michael, Fournel, Pierre, Cardenal, Felipe, Bezjak, Andrea, Blackhall, Fiona
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2016
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4735219/
https://ncbi.nlm.nih.gov/pubmed/26792218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-009849
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky